compostos contendo benzo[d][1,3]oxatiol, 3-óxido de benzo[d][1,3]oxatiol ou 3,3-dióxido de benzo[d][1,3]oxatiol e métodos/usos dos mesmos como agonistas do receptor 119 acoplado a proteína g
são fornecidos compostos contendo benzo[d][1,3]oxatiol, 3-óxido de benzo[d][1,3]oxatiol ou 3,3-dióxido de benzo[d][1,3]oxatiol, bem como usos/métodos relacionados aos mesmos, incluindo tratamento de doenças e condições associadas com desregulação do gpr119, diabetes mellitus do tipo 2 e distúrbios m...
Gespeichert in:
Hauptverfasser: | , , , , |
---|---|
Format: | Patent |
Sprache: | por |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | ALEKSANDR NIKITIN TAREK SUHAYL MANSOUR MIKHAIL YUDIN YURY GEZENTSVEY MIKHAIL CHAFEEV |
description | são fornecidos compostos contendo benzo[d][1,3]oxatiol, 3-óxido de benzo[d][1,3]oxatiol ou 3,3-dióxido de benzo[d][1,3]oxatiol, bem como usos/métodos relacionados aos mesmos, incluindo tratamento de doenças e condições associadas com desregulação do gpr119, diabetes mellitus do tipo 2 e distúrbios metabólicos relacionados.
There are provided compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide, and benzo[d][1,3]oxathiole 3,3-dioxide, as well as uses/methods related thereto, including treatment of diseases and condition associated with GPR119 dysregulation, Type 2 diabetes mellitus, and related metabolic disorders. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR112018075484A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR112018075484A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR112018075484A23</originalsourceid><addsrcrecordid>eNqNjrFqAkEYhK9JISbv8Dd2d8R1Fc_ShATrkE5Efnd_5eB2Z7ndA_GNLFL5BrkXyyWkFLSaYeaDmUH2beACYkIkA5_EW9BO_Alru1mrXG9w5FShzkkX3eVY9bWVqwShJZ3rwlY3OCHXnRMs4nMb-93ekJPo_i44EB_gq5j4t6FGjISEhpRaEBuEmvuUKTRI0n15psNj9rDnOsrTvw6z0fvb5-uqkICtxMBGvKTty4dSk7Eqx_PZtJwuJ_pe7gelL2Ot</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>compostos contendo benzo[d][1,3]oxatiol, 3-óxido de benzo[d][1,3]oxatiol ou 3,3-dióxido de benzo[d][1,3]oxatiol e métodos/usos dos mesmos como agonistas do receptor 119 acoplado a proteína g</title><source>esp@cenet</source><creator>ALEKSANDR NIKITIN ; TAREK SUHAYL MANSOUR ; MIKHAIL YUDIN ; YURY GEZENTSVEY ; MIKHAIL CHAFEEV</creator><creatorcontrib>ALEKSANDR NIKITIN ; TAREK SUHAYL MANSOUR ; MIKHAIL YUDIN ; YURY GEZENTSVEY ; MIKHAIL CHAFEEV</creatorcontrib><description>são fornecidos compostos contendo benzo[d][1,3]oxatiol, 3-óxido de benzo[d][1,3]oxatiol ou 3,3-dióxido de benzo[d][1,3]oxatiol, bem como usos/métodos relacionados aos mesmos, incluindo tratamento de doenças e condições associadas com desregulação do gpr119, diabetes mellitus do tipo 2 e distúrbios metabólicos relacionados.
There are provided compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide, and benzo[d][1,3]oxathiole 3,3-dioxide, as well as uses/methods related thereto, including treatment of diseases and condition associated with GPR119 dysregulation, Type 2 diabetes mellitus, and related metabolic disorders.</description><language>por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190319&DB=EPODOC&CC=BR&NR=112018075484A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190319&DB=EPODOC&CC=BR&NR=112018075484A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ALEKSANDR NIKITIN</creatorcontrib><creatorcontrib>TAREK SUHAYL MANSOUR</creatorcontrib><creatorcontrib>MIKHAIL YUDIN</creatorcontrib><creatorcontrib>YURY GEZENTSVEY</creatorcontrib><creatorcontrib>MIKHAIL CHAFEEV</creatorcontrib><title>compostos contendo benzo[d][1,3]oxatiol, 3-óxido de benzo[d][1,3]oxatiol ou 3,3-dióxido de benzo[d][1,3]oxatiol e métodos/usos dos mesmos como agonistas do receptor 119 acoplado a proteína g</title><description>são fornecidos compostos contendo benzo[d][1,3]oxatiol, 3-óxido de benzo[d][1,3]oxatiol ou 3,3-dióxido de benzo[d][1,3]oxatiol, bem como usos/métodos relacionados aos mesmos, incluindo tratamento de doenças e condições associadas com desregulação do gpr119, diabetes mellitus do tipo 2 e distúrbios metabólicos relacionados.
There are provided compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide, and benzo[d][1,3]oxathiole 3,3-dioxide, as well as uses/methods related thereto, including treatment of diseases and condition associated with GPR119 dysregulation, Type 2 diabetes mellitus, and related metabolic disorders.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjrFqAkEYhK9JISbv8Dd2d8R1Fc_ShATrkE5Efnd_5eB2Z7ndA_GNLFL5BrkXyyWkFLSaYeaDmUH2beACYkIkA5_EW9BO_Alru1mrXG9w5FShzkkX3eVY9bWVqwShJZ3rwlY3OCHXnRMs4nMb-93ekJPo_i44EB_gq5j4t6FGjISEhpRaEBuEmvuUKTRI0n15psNj9rDnOsrTvw6z0fvb5-uqkICtxMBGvKTty4dSk7Eqx_PZtJwuJ_pe7gelL2Ot</recordid><startdate>20190319</startdate><enddate>20190319</enddate><creator>ALEKSANDR NIKITIN</creator><creator>TAREK SUHAYL MANSOUR</creator><creator>MIKHAIL YUDIN</creator><creator>YURY GEZENTSVEY</creator><creator>MIKHAIL CHAFEEV</creator><scope>EVB</scope></search><sort><creationdate>20190319</creationdate><title>compostos contendo benzo[d][1,3]oxatiol, 3-óxido de benzo[d][1,3]oxatiol ou 3,3-dióxido de benzo[d][1,3]oxatiol e métodos/usos dos mesmos como agonistas do receptor 119 acoplado a proteína g</title><author>ALEKSANDR NIKITIN ; TAREK SUHAYL MANSOUR ; MIKHAIL YUDIN ; YURY GEZENTSVEY ; MIKHAIL CHAFEEV</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR112018075484A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ALEKSANDR NIKITIN</creatorcontrib><creatorcontrib>TAREK SUHAYL MANSOUR</creatorcontrib><creatorcontrib>MIKHAIL YUDIN</creatorcontrib><creatorcontrib>YURY GEZENTSVEY</creatorcontrib><creatorcontrib>MIKHAIL CHAFEEV</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ALEKSANDR NIKITIN</au><au>TAREK SUHAYL MANSOUR</au><au>MIKHAIL YUDIN</au><au>YURY GEZENTSVEY</au><au>MIKHAIL CHAFEEV</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>compostos contendo benzo[d][1,3]oxatiol, 3-óxido de benzo[d][1,3]oxatiol ou 3,3-dióxido de benzo[d][1,3]oxatiol e métodos/usos dos mesmos como agonistas do receptor 119 acoplado a proteína g</title><date>2019-03-19</date><risdate>2019</risdate><abstract>são fornecidos compostos contendo benzo[d][1,3]oxatiol, 3-óxido de benzo[d][1,3]oxatiol ou 3,3-dióxido de benzo[d][1,3]oxatiol, bem como usos/métodos relacionados aos mesmos, incluindo tratamento de doenças e condições associadas com desregulação do gpr119, diabetes mellitus do tipo 2 e distúrbios metabólicos relacionados.
There are provided compounds containing benzo[d][1,3]oxathiole, benzo[d][1,3]oxathiole 3-oxide, and benzo[d][1,3]oxathiole 3,3-dioxide, as well as uses/methods related thereto, including treatment of diseases and condition associated with GPR119 dysregulation, Type 2 diabetes mellitus, and related metabolic disorders.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | por |
recordid | cdi_epo_espacenet_BR112018075484A2 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | compostos contendo benzo[d][1,3]oxatiol, 3-óxido de benzo[d][1,3]oxatiol ou 3,3-dióxido de benzo[d][1,3]oxatiol e métodos/usos dos mesmos como agonistas do receptor 119 acoplado a proteína g |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T15%3A04%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ALEKSANDR%20NIKITIN&rft.date=2019-03-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR112018075484A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |